Personalis, Inc. (PSNL)

USD 3.56

(-7.29%)

Total Debt Summary of Personalis, Inc.

  • Personalis, Inc.'s latest annual total debt in 2023 was 48.96 Million USD , up 0.64% from previous year.
  • Personalis, Inc.'s latest quarterly total debt in 2024 Q1 was 47.82 Million USD , down -2.33% from previous quarter.
  • Personalis, Inc. reported annual total debt of 48.65 Million USD in 2022, down -7.85% from previous year.
  • Personalis, Inc. reported annual total debt of 52.79 Million USD in 2021, up 380.58% from previous year.
  • Personalis, Inc. reported quarterly total debt of 47.82 Million USD for 2024 Q1, down -2.33% from previous quarter.
  • Personalis, Inc. reported quarterly total debt of 49.48 Million USD for 2023 Q1, up 1.71% from previous quarter.

Annual Total Debt Chart of Personalis, Inc. (2023 - 2017)

Historical Annual Total Debt of Personalis, Inc. (2023 - 2017)

Year Total Debt Total Debt Growth
2023 48.96 Million USD 0.64%
2022 48.65 Million USD -7.85%
2021 52.79 Million USD 380.58%
2020 10.98 Million USD 707.2%
2019 1.36 Million USD -72.76%
2018 4.99 Million USD -71.46%
2017 17.5 Million USD 0.0%

Peer Total Debt Comparison of Personalis, Inc.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD 44.328%
Prenetics Global Limited 2.36 Million USD -1966.441%
Star Equity Holdings, Inc. 3.6 Million USD -1256.664%
CareDx, Inc 34.22 Million USD -43.076%
Exact Sciences Corporation 2.55 Billion USD 98.083%
Exagen Inc. 23.72 Million USD -106.408%
Inotiv, Inc. 417.64 Million USD 88.277%
Guardant Health, Inc. 1.35 Billion USD 96.383%
Biodesix, Inc. 60.69 Million USD 19.326%
BioNexus Gene Lab Corp. 133.39 Thousand USD -36604.524%
Precipio, Inc. 1.11 Million USD -4287.276%
iSpecimen Inc. 196.24 Thousand USD -24849.553%
Natera, Inc. 441.99 Million USD 88.922%
Aspira Women's Health Inc. 2.26 Million USD -2060.724%
Standard BioTools Inc. 98.21 Million USD 50.146%
23andMe Holding Co. 76.51 Million USD 36.01%
Castle Biosciences, Inc. 15.31 Million USD -219.804%
Aclaris Therapeutics, Inc. 426 Thousand USD -11393.427%
Applied DNA Sciences, Inc. 1.23 Million USD -3855.694%
OpGen, Inc. 13.04 Million USD -275.369%
T2 Biosystems, Inc. 49.49 Million USD 1.083%
Myriad Genetics, Inc. 145 Million USD 66.233%
ICON Public Limited Company 3.93 Billion USD 98.757%
NeoGenomics, Inc. 611.67 Million USD 91.995%
Star Equity Holdings, Inc. 3.6 Million USD -1256.664%
IDEXX Laboratories, Inc. 947.88 Million USD 94.835%
RadNet, Inc. 1.49 Billion USD 96.716%
MDxHealth SA 41.26 Million USD -18.653%
Psychemedics Corporation 2.29 Million USD -2030.635%
Illumina, Inc. 2.26 Billion USD 97.835%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD 47.951%
DarioHealth Corp. 29.54 Million USD -65.743%
Fulgent Genetics, Inc. 14.9 Million USD -228.45%
Sera Prognostics, Inc. 1.85 Million USD -2535.199%
ENDRA Life Sciences Inc. 394.4 Thousand USD -12314.206%
OPKO Health, Inc. 326.56 Million USD 85.007%
Medpace Holdings, Inc. 142.12 Million USD 65.549%
Neogen Corporation 906.23 Million USD 94.597%
Intelligent Bio Solutions Inc. 871.44 Thousand USD -5518.516%
Prenetics Global Limited 2.36 Million USD -1966.441%
Mainz Biomed B.V. 7.42 Million USD -559.796%
bioAffinity Technologies, Inc. 1.57 Million USD -3001.532%
Trinity Biotech plc 67.42 Million USD 27.385%
Neuronetics, Inc. 62.47 Million USD 21.628%
Sotera Health Company 2.32 Billion USD 97.896%
bioAffinity Technologies, Inc. 1.57 Million USD -3001.532%